FDA 483 - Chemdex Inc - July 15, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Chemdex Inc. in Lenexa, KS, revealed a critical failure in the quality unit's oversight of cleaning and maintenance systems for equipment used in manufacturing sterile drug products. Specifically, cleaning validation studies did not address microbiological or endotoxin contamination, and processes for reviewing reactor inspections and addressing recommended maintenance were not established. These issues pose a risk to the sterility and quality of their drug products.
ID · bb106d2e-9fd9-4466-9ec3-f6dc05044089